title: Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: a potent system of proteolysis control.
abstract: During the reproductive cycle, ovarian follicles undergo major tissue-remodeling involving vascular changes and proteolysis. Anticoagulant heparan sulfate proteoglycans (aHSPGs) are expressed by granulosa cells during the development of the ovarian follicle. The function of aHSPGs in the ovary is unknown, but they might be involved in proteolysis control through binding and activation of serine protease inhibitors. To identify functional interactions between aHSPGs and heparin-binding protease inhibitors in the follicle, we have coordinately localized aHSPGs, antithrombin III, protease nexin-1, and plasminogen activator inhibitor-1 in the rat ovary during natural and gonadotropin-stimulated cycles. Anticoagulant HSPGs were visualized by autoradiography of cryosections incubated with 125I-antithrombin III, and protease inhibitors were assessed by immunohistochemistry and Northern blot hybridization. Anticoagulant HSPGs were expressed in follicles before ovulation, were transiently decreased in postovulatory follicles, and were abundant in the corpus luteum, mainly on capillaries. Anticoagulant HSPGs were colocalized with protease nexin-1 in follicles from the early antral stage until ovulation, with antithrombin III in the preovulatory stage and after ovulation, and with plasminogen activator inhibitor-1 in the corpus luteum. These data demonstrate that aHSPGs are critically expressed in the ovary to interact sequentially with protease nexin-1, antithrombin III, and plasminogen activator inhibitor-1 during the cycle. The specificity of these inhibitors is shifted toward thrombin inhibition in the presence of heparin, suggesting that aHSPGs direct their action to control fibrin deposition in the follicle. The occupation of aHSPGs antithrombin-binding sites by mutant R393C antithrombin III, injected in the ovarian bursa, decreased ovulation efficiency, further supporting the involvement of aHSPGs in the ovulation process.
authors.affiliation: Infertility Clinic, Department of Gynaecology and Obstetrics, Geneva University Hospital, 1211 Geneva 14, Switzerland.
authors.forename: Shereen
authors.initials: S
authors.lastname: Hasan
authors.forename: Ghamartaj
authors.initials: G
authors.lastname: Hosseini
authors.forename: Marc
authors.initials: M
authors.lastname: Princivalle
authors.forename: Ji-Cui
authors.initials: JC
authors.lastname: Dong
authors.forename: Daniela
authors.initials: D
authors.lastname: Birsan
authors.forename: Cristina
authors.initials: C
authors.lastname: Cagide
authors.forename: Ariane I
authors.initials: AI
authors.lastname: de Agostini
mesh_terms: D016564:Amyloid beta-Protein Precursor; D000818:Animals; D000925:Anticoagulants / Q000097:blood*; D015152:Blotting, Northern; D002352:Carrier Proteins / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D030762:Estrous Cycle / Q000502:physiology; D005260:Female; D005337:Fibrin / Q000378:metabolism; D006107:Granulosa Cells / Q000378:metabolism; D019812:Heparan Sulfate Proteoglycans / Q000096:biosynthesis* / Q000502:physiology*; D007150:Immunohistochemistry; D010053:Ovary / Q000378:metabolism*; D010060:Ovulation / Q000502:physiology; D017395:Plasminogen Activator Inhibitor 1 / Q000096:biosynthesis; D058255:Protease Nexins; D012313:RNA / Q000302:isolation & purification; D051381:Rats; D017207:Rats, Sprague-Dawley; D011956:Receptors, Cell Surface; D015842:Serine Proteinase Inhibitors / Q000096:biosynthesis*; D015843:Serpins / Q000096:biosynthesis
chemical_list: D016564:Amyloid beta-Protein Precursor; D000925:Anticoagulants; D002352:Carrier Proteins; D019812:Heparan Sulfate Proteoglycans; D017395:Plasminogen Activator Inhibitor 1; D058255:Protease Nexins; D011956:Receptors, Cell Surface; D015842:Serine Proteinase Inhibitors; D015843:Serpins; D012313:RNA; D005337:Fibrin